Budget Impact of Somatostatin Analogs (SSAs) as Treatment for Metastatic Gastroenteropancreatic Neuroendocrine Tumors (mGEP-NETs) in US Hospitals

European Neuroendocrine Tumor Society Conference
Budget Impact Model, Cancer, Economic Models, Gastroenterology, Neuroendocrine Tumors, Oncology

Economic Implications of Instituting Clinical Care Pathways in Metastatic Colorectal Cancer

AMCP Managed Care & Specialty Pharmacy Annual Meeting
Budget Impact Model, Cancer, Colorectal Cancer, Economic Models, Oncology

Budget Impact Analysis of Increasing LMWH/FXI Utilization

ISPOR Annual International Meeting
Budget Impact Model, Cardiology, Cost Effectiveness Analysis, Economic Models, Thromboembolism